As a matter of fact, NKG2D-CAR-transduced NK cells demonstrated higher killing activity and efficacy in targeting Multiple Myeloma cells towards NKG2D-CAR-transduced T cells [25]. The gene discussed is KLRK1; the disease is AL amyloidosis.